Skip to main content
Earnings Labs
Erasca, Inc. logo

Erasca, Inc. (ERAS)

NASDAQ·Healthcare·Biotechnology

$18.54

+3.95%

Mkt Cap $6.55B

Analyst Ratings

Buy

8

Hold

3

Sell

0

Price Target (17 analysts)

$17.50

Range $10.00$30.00

Implied Upside

-5.6%

Consensus $17.50 vs current $18.54